GSK’s candidate Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Demonstrates 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Yea
Go back to GSK’s candidate Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Demonstrates 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Yea| AGENUS (NASDAQ: AGEN) | Delayed: 3.07 +0.03 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $7.49 | |||
| Open | $2.99 | 52 Week Low | $2.61 | |||
| Day High | $3.18 | P/E | N/A | |||
| Day Low | $2.99 | EPS | $-1.10 | |||
| Volume | 438,570 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 52.07 +1.33 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.74 | 52 Week High | $45.58 | |||
| Open | $51.63 | 52 Week Low | $37.82 | |||
| Day High | $52.12 | P/E | N/A | |||
| Day Low | $51.51 | EPS | $0.00 | |||
| Volume | 3,008,311 | |||||

